Africa: New Injectable HIV Treatment Shows Promise in Africa, Study Finds

Africa: New Injectable HIV Treatment Shows Promise in Africa, Study Finds

Nairobi — A new study conducted across three African countries has found that an injectable HIV treatment–Cabotegravir/Rilpivirine (CAB LA + RPV LA), administered every two months–is safe, well tolerated, and preferred by most patients. The Month-12 results, drawn from study sites in Kenya, Uganda, and South Africa, offer renewed hope for improved treatment adherence, fewer…

Read More
Africa: New Injectable HIV Treatment Shows Promise in Africa, Study Finds

Africa Holds Promise Toward SDGs Amid Challenges – UN

ADDIS ABABA – Africa’s youthful population and digital momentum position the continent as both vulnerable and uniquely poised to accelerate progress toward the Sustainable Development Goals (SDGs), according to UN’s 2025 SDG report. With just five years remaining until the 2030 deadline, the report reveals that only one-third of the goals are showing sufficient progress….

Read More